Publications by authors named "Yoshiko Numata"

Claim this Profile
R
REV7 subunit of mutagenic DNA polymerase ζ as a predictive biomarker for the efficacy of immune checkpoint inhibitor therapy in melanoma.
Akiyoshi Hoshino, Koya Obara, Masaaki Ichinoe, Takuya Kato, Yasutaka Sakurai, Yoshiko Numata

J Clin Pathol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma.
Yurika Kesen, Masaaki Ichinoe, Shoko Hayashi, Atsuko Umezawa, Yoshiko Numata

Pathol Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Yoshiko Numata

Cancer Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
["Exclusivity" and quantifier float in "Exclusivity" and quantifier float in ].
Takashi Otsuka, Ryo Shirakawa, Osamu Hashimoto, Yoshiko Numata

F1000Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of REV7 correlates with progression of malignant melanoma.
Akiyoshi Hoshino, Chika Nakayama, Shi-Xu Jiang, Yasutaka Sakurai, Takuya Kato, Yoshiko Numata

Pathol Int· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation.
Itaru Sanoyama, Yasutaka Sakurai, Masaaki Ichinoe, Akiyoshi Hoshino, Yurika Kesen, Yoshiko Numata

Pathol Int· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors.
Yasutaka Sakurai, Masaaki Ichinoe, Kazuki Yoshida, Yuka Nakazato, Shoji Saito, Yoshiko Numata

Cancer Lett· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
Maki Yokoyama, Masaaki Ichinoe, Sosei Okina, Yasutaka Sakurai, Norihiro Nakada, Yoshiko Numata

Int J Hematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab.
Sosei Okina, Nobuyuki Yanagisawa, Maki Yokoyama, Yasutaka Sakurai, Yoshiko Numata

Int J Hematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
Jing-Min Zhang, Yoshiki Murakumo, Sumitaka Hagiwara, Ping Jiang, Shinji Mii, Yoshiko Numata

Biochem Biophys Res Commun· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α-smooth muscle actin expression.
Tetuo Mikami, Yuta Nemoto, Yoshiko Numata, Kiyomi Hana, Norihiro Nakada

Hum Pathol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of D2-40 and MMP-1 expression with cyst formation in lung metastatic lesions of cutaneous angiosarcoma on the scalp: immunohistochemical analysis of 23 autopsy cases.
Mamiko Masuzawa, Tetuo Mikami, Yoshiko Numata, Wataru Tokuyama, Mikio Masuzawa

Hum Pathol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression.
Masahiko Takeda, Tetuo Mikami, Yoshiko Numata, Makito Okamoto, Isao Okayasu

Am J Clin Pathol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma.
Tetuo Mikami, Tsutomu Yoshida, Yoshiko Numata, Masaomi Kikuchi, Kayo Araki

Diagn Pathol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis.
Hiroko Yagishita, Tsutomu Yoshida, Kayo Ishiguro, Yoshiko Numata, Isao Okayasu

Scand J Gastroenterol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: comparison with sporadic colonic tumors.
Tetuo Mikami, Tsutomu Yoshida, Yoshiko Numata, Hiroaki Shiraishi, Kayo Araki

Am J Clin Pathol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
Tsutomu Yoshida, Shiori Haga, Yoshiko Numata, Kazuya Yamashita, Tetuo Mikami

Int J Cancer· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis